Home
Company
Portfolio
About
View By Area
View By Status
View by company A-Z
Investor Relations
English
Swedish
Press
English
Swedish
Contact
English
Swedish
Sitemap
Portfolio
Cardiovascular
Athera Biotechnologies AB
CNS
BioChromix Pharma AB
Umecrine Cognition AB
Dermatology and Wound Healing
Pergamum AB
DPK-060 - DermaGen
LL-37 - Lipopeptide
PXL01 - PharmaSurgics in Sweden
Infectious Disease
Biosergen AS
Dilaforette AB
Inflammation
NovaSAID AB
ProNoxis AB
Oncology
Akinon Pharmaceuticals AB
Aprea AB
Axelar AB
GliGene AB
KDev Oncology AB
Oncopeptides AB
Ophthalmology
Clanotech AB
Women's Health
Dilafor AB
Umecrine Mood AB
Pharmanest AB
Technology
Inhalation Sciences Sweden AB
Lipidor AB
NeoDynamics AB
Oss-Q AB
Promimic AB
XSpray Microparticles AB
Theranostics
Athera Biotechnologies AB
BioChromix AB
Passive Investments
Pharmaceutical
Bioneris AB
BioArctic Neuroscience AB
CytoGuide ApS
NephroGenex Inc.
Technology
Investor relations
English
Financial Reports
Press Releases
Contact IR
Financial Calendar
Analysts
Contact IR
Subscribe
Corporate Governance
General Meetings
CEO
Board of DIrectors
Nomination Committee
Auditors
Code of Corporate Governance
Articles of Association
Corporate Governance Report
Incentive Scheme
Swedish
Finansiella Rapporter
Pressreleaser
Finansiell Kalender
Analytiker
Kontakt IR
Prenumerera
Bolagsstyrning
Bolagsstämma
VD
Styrelsen
Valberedning
Revisor
Bolagskod
Bolagsordning
Bolagsstyrningsrapport
Incitamentprogram
Company
Business Model
Background
Pharmaceutical Development Process
Actar
Policies & Ethics
Board of Directors
Management
Personnel
Press
Press Releases
News
Image Archive
Contact
Contact Press
